To receive news and publication updates for Journal of Immunology Research, enter your email address in the box below.

Confirmation email sent.

Novel Cancer Immunotherapies and Antitumor Immunity

Call for Papers

Nowadays, antibody has been widely used in cancer treatment. However, due to the complexity and heterogeneity of cancer, the acquired resistance is one of the prime obstacles in the way of cancer treatment and development of novel cancer immunotherapies with potent antitumor activities and specificities are urgently needed. Recently, the success of PD-1/PD-L1 therapeutic antibodies in clinic has revealed that blockade of tumor-associated immunosuppression and initiation of tumor-specific immunity could be critical for the development of novel immunotherapies against cancer. How to efficiently induce tumor-specific immunity would be important for the development of novel cancer immunotherapies in the future.

The high-quality original research articles as well as review articles are invited to understand and clarify the related knowledge and mechanism of antitumor immune response and contribute to the development of novel cancer immunotherapies with high efficacy to induce antitumor immunity.